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Abstract
Innate immune responses have a critical role in regulating sight-threatening ocular surface (OcS) inflammation. While
glucocorticoids (GCs) are frequently used to limit tissue damage, the role of intracrine GC (cortisol) bioavailability via 11-
beta-hydroxysteroid dehydrogenase type 1 (11b-HSD1) in OcS defense, remains unresolved. We found that primary human
corneal epithelial cells (PHCEC), fibroblasts (PHKF) and allogeneic macrophages (M1, GM-CSF; M2, M-CSF) were capable of
generating cortisol (M1.PHKF.M2.PHCEC) but in corneal cells, this was independent of Toll-like receptor (TLR) activation.
While PolyI:C induced maximal cytokine and chemokine production from both PHCEC (IFNc, CCL2, CCL3, and (CCL4), IL6,
CXCL10, CCL5, TNFa) and PHKF (CCL2, IL-6, CXCL10, CCL5), only PHKF cytokines were inhibited by GCs. Both Poly I:C and LPS
challenged-corneal cells induced M1 chemotaxis (greatest LPS-PHKF (250%), but down-regulated M1 11b-HSD1 activity (30
and 40% respectively). These data were supported by clinical studies demonstrating reduced human tear film
cortisol:cortisone ratios (a biomarker of local 11b-HSD1 activity) in pseudomonas keratitis (1:2.9) versus healthy controls
(1:1.3; p,0.05). This contrasted with putative TLR3-mediated OcS disease (Stevens-Johnson Syndrome, Mucous membrane
pemphigoid) where an increase in cortisol:cortisone ratio was observed (113.8:1; p,0.05). In summary, cortisol biosynthesis
in human corneal cells is independent of TLR activation and is likely to afford immunoprotection under physiological
conditions. Contribution to ocular mucosal innate responses is dependent on the aetiology of immunological challenge.
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Introduction
Ocular surface (OcS) pathology is a leading cause of worldwide
blindness and represents a major proportion of ophthalmological
emergencies in the developed world. The OcS provides an
intricate mucosal barrier against infectious pathogens and
immune-mediated processes that trigger innate responses. Unlike
other mucosal surfaces the cornea is avascular and optically clear,
and supports a highly complex tear film that is vital for lubrication,
nutrition and immunological defence of the eye. The tear film
ultrastructure comprises (i) a negatively charged, hydrophilic
mucinous glycocalyx that limits adhesion of foreign debris or
pathogens to the OcS, (ii) a more superficial nutritive aqueous
phase consisting of a range of electrolytes, carbohydrates, anti-
oxidants, vitamins, proteins, immunoglobulins, hormones, growth
factors and cytokines that support epithelial cell proliferation,
maturation and movement across the ocular surface, and (iii) a
complex triplex lipid layer consisting of outer non-polar lipids,
inner polar lipids with intercalated proteins together with a novel
long chain (O-acyl)-v-hydroxy fatty acid functioning as an
intermediate surfactant lipid interface [1]. Immunological damage
of the OcS results in mucosal inflammatory cell invasion,
angiogenesis and ultimately a blinding keratopathy.
The tissue-specific regulation of the active glucocorticoid (GC),
cortisol, is a purported mechanism for determining the length and
type of inflammatory response [2–4]. The actions of GCs are
largely mediated via the glucocorticoid receptor (GRa) that acts as
a nuclear transcription factor for a variety of GC responsive genes
and has been implicated in the pathogenesis of disease [5–8].
Systemic regulation of cortisol levels are controlled by the
hypothalamic-pituitary-adrenal axis, but local regulation is medi-
ated via the 11b-hydroxysteroid dehydrogenases (11b-HSDs).
Two isoforms control the cortisol-cortisone shuttle [9]: 11b-HSD2
inactivating cortisol to cortisone [10,11] in sodium and water
secreting tissues protecting the mineralocorticoid receptor from
GC excess, and 11b-HSD1 inducing GRa through activation of
cortisol. 11b-HSD1 exhibits bidirectional enzyme activity in vitro,
but in vivo, functions as an oxo-reductase, converting cortisone to
cortisol - a reaction which is dependent on the delivery of co-factor
NADPH via hexose-6-phosphate dehydrogenase (H6PD) and the
glucose-6-phosphate transporter [12]. In the eye, our earlier work
has localised 11b-HSD1 to the basal cells of the central corneal
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(differentiated) epithelium, and serum and glucocorticoid-regulat-
ed kinase 1 (SGK1, a GR mediated target gene) to the actively
proliferating peripheral limbal region [13,14]. The importance of
GCs in maintaining the integrity of the corneal epithelium is
further supported by analyses of cultured rabbit corneal epithelial
cells (CECs)[3]. More recently we have shown that synthetic GCs,
such as dexamethasone, are able to change the global gene and
miR profile of corneal fibroblasts down-regulating inflammatory
genes and inducing expression of anti-angiogenic and anti-
inflammatory genes [15].
During pathogen-driven processes, the recognition of pathogen
products occurs via receptors such as Nod-Like Receptors (NLR),
NALPS/inflammasomes, RIG-I-like receptors (RLR) and Toll like
Receptors (TLR) [16]. Several TLR have been shown to be
expressed in the cornea with TLR 1–6 and TLR 9–10 in human
conjunctival and limbal epithelial cells [17], and TLR3 in primary
human corneal epithelial cells (PHCEC) [18]. The absence of
expression of TLR7 and TLR8 in primary cells is of interest, as
this suggests that PHCEC and primary human corneal fibroblasts
(PHKF) do not respond to ssDNA and dsDNA through these
receptors. TLR induction in these cells produce cytokines (IL-6,
IL-8 and TNFa) but data are limited as no studies have examined
a wider cytokine profile in order to interrogate disease signaling
pathways in more detail. This is particularly relevant as TLR
recognition of pathogen-derived products is also known to trigger
an activating signal for the innate immune system during not only
ocular infections, but also dry eye disease states and immune-
mediated OcS disease such as Stevens-Johnson Syndrome/Toxic
epidermal necrolysis (SJS-TEN) where ongoing sub-clinical
inflammation remains a therapeutic challenge [16,19–23].
In addition, macrophages and immature dendritic cells (iDCs)
also respond to pathogens. Response may be direct via receptors
such as the TLR or indirect, through cytokines and chemokines
released by barrier cells under threat of the originating innate
immune challenge agent. The autocrine regulation of 11b-HSD1
is pivotal; balancing the cortisol and cortisone shuttle appears to be
a contributory driver of monocyte maturation, immune-cell
function and down-regulation of tissue damaging inflammation
[24,25]. This could be particularly relevant in ocular disease where
the optically clear media are paradoxically compromised by the
innate immune response that is vital for eradication of the
triggering agent.
In this study, we used a combination of in vitro and clinical
studies to examine the interplay between TLR and GCs in the
context of OcS health, and when the OcS is actively threatened by
microbial insult or immune-mediated disease, to determine
whether the local provision of GCs contributes to the innate
immunity of the OcS in health and in disease.
Materials and Methods
Human corneal cells
Ethics Statement. The study was undertaken after formal
ethics approval from the Black Country Research Ethics
Committee (incorporating the Dudley Research Ethics Committee
(LREC 06/Q2702/44)), and all experiments were carried out in
accordance with the Tenets of the Declaration of Helsinki.
Donor peripheral corneal rims and central corneal buttons
(transplant waste) from penetrating and lamellar keratoplasty
surgical procedures, where the donor had given written informed
consent for research were used for the culture of primary human
corneal epithelial cells (PHCEC) and corneal fibroblasts (PHKF).
According to United Kingdom Guidelines for Organ Donation,
only those patients with normal eyes in the absence of absolute
exclusion criteria including active transmissible disease or infec-
tion, Creuzfeldt-Jakob Disease, intravenous drug abuse, and
neurodegenerative disorders, are suitable to donate organs and
tissues for transplantation. Additional exclusions include previous
ocular surgery, inflammation and tumors such as retinoblastoma.
The average age of the corneal donors was 69.1 (range 18–81.2)
years. The corneal–scleral rims were incubated for 2 h at 37uC
with 1.2 IU/ml neutral protease (Dispase II, Roche). Using a
surgical ‘hockey stick’, the epithelium was stripped off with gentle
scraping radially from the limbus towards the corneal apex in
phosphate buffered saline (PBS). PHCEC were maintained in
keratinocyte serum-free medium (KSFM) supplemented with
0.05 mg/mL bovine pituitary extract, 5 ng/mL human recombi-
nant epidermal growth factor (Invitrogen, CA), 50 000 U/I
penicillin and 50 000 mg/l streptomyocin, and 5% fetal calf serum
(FCS) (Sigma, UK). Cells were grown at 37uC in a humid
environment containing 5% CO2 and the cell culture media was
changed every 2 to 3 days.
PHKF were generated from corneal tissue excised from the
corneoscleral rims. The corneal epithelial layer was removed from
the stroma using dispase enzyme digestion, and the endothelial
layer stripped under direct visualisation with the aid of trypan
blue. The remaining corneal stroma was chopped into small pieces
and cultured in a 25 cm2 flask with 2 mL Fibro-medium. Cells
were grown at 37uC in a humid environment containing 5% CO2
and the cell culture media was changed every 2 to 3 days.
Confluent cells were trypsinised and only cells up to 4 generations
were used for subsequent experiments.
The identity of the cell types were confirmed by immunocyto-
chemical analyses for cytokeratin 3, anti-vimentin and anti-5B5 as
previously described [15]. The PHCEC were identified by their
hexagonal morphology and CK3+/vimentin+/5B52 staining
characteristics, whereas PHKF exhibited an elongated morphol-
ogy and CK32/vimentin+/5B5+.
Monocyte-derived macrophages
Homogenous macrophage populations were generated by
isolating peripheral blood mononuclear cells cells (PBMC) from
the venous blood of healthy volunteers incubating pellets for at
least 15 minutes in 20 ml of CD14+ beads (Miltenyi Biotech, UK)
and 80 ml of MACS buffer (Miltenyi Biotech) per 16107/ml
PBMC. Cells were then washed twice using MACS buffer and
passed through a MACS column inserted into a magnetic holder.
Negative subsets were excluded in the run through of column. The
column was then removed from the holder and CD14+ cells were
collected by washing and set up in complete media at an
appropriate concentration. To grow M1 or M2 macrophages
either 10 ng/ml of recombinant human GM-CSF (PeproTech,
UK) or 50 ng/ml recombinant human M-CSF (PeproTech, UK),
respectively, was added to purified monocytes in complete
medium; RPMI 1640 media supplemented with 10 mM L-
Glutamine, and 5000 U/ml penicillin with 10 mg/ml Streptomy-
cin (GPS) with 10% heated inactivated fetal calf serum (HIFCS)
(all Sigma UK) and 4% human serum (HD Supplies UK) and
incubated at 37uC in a humidified atmosphere of 5% CO2 for 6–7
days and harvested for use.
11b-HSD enzyme assays
Cells grown to confluence were pre-treated with 10 ng/ml of
cytokines (IL-1, IL6, IL-8, TNFa, IL-4, IL-10, IL-13; Peprote-
ch,UK) for 24 h and 1 mg/ml LPS (Sigma UK) for 48 h in serum
containing KSFM before the start of the assay. Dehydrogenase
activity (cortisol to cortisone conversion) was assessed using
100 nM unlabelled cortisol (Sigma, UK) diluted in growth
Glucocorticoids and the Ocular Surface
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medium and tracer amounts (1.5 nM) of [3H]cortisol (specific
activity 74.0 Ci/mmol; NEN, USA) at 37uC for 24 h. Conversion
of cortisone to cortisol (oxo-reductase activity) was analysed by
incubating cells with 100 nM cortisone and tracer amounts of
[3H]cortisone (50000 cpm synthesised in-house) with or without
cytokines. After 24 h incubation, steroids were extracted from the
medium with ten volumes of dichloromethane, separated by thin-
layer chromatography with chloroform:ethanol (92:8) as a mobile
phase and the fractional conversion of steroids was calculated after
scanning analysis using a Bioscan 2000 radioimaging detector
(Bioscan, Washington, DC, USA). Following enzyme assay, cell
monolayers were lysed in 1 ml water for subsequent protein assays.
Total protein in each well was determined using a standard
protein assay reagent (Bio-Rad), and enzyme activities were
expressed as pmol/mg/h.
RNA isolation and reverse-transcription (RT)
Total RNA was extracted from cells according to the
manufacturer’s instructions (Tri reagent, Sigma, UK) using. Total
RNA was DNase I treated to remove any genomic DNA
contamination (Invitrogen, CA). The quantity and quality of
mRNA was assessed spectrophotometrically at and optical density
of 260 /280 nm and by electrophoresis of 2 ml on a 1% agarose
gel. Total RNA (100 ng-1 mg) in a total volume of 50 ml was
reverse-transcribed using Multiscribe reverse transcriptase and
random hexamers according to manufacturer’s protocol (Applied
Biosystems, UK). cDNA (50 ng) was used for conventional
polymerase chain reaction (PCR) to define the expression of the
genes of interest.
Polymerase chain reaction (PCR)
RT was performed as above and 2 ml cDNA (PHCEC, PHKF)
was used in subsequent PCR reactions for the following genes:
11b-HSD1; 11b-HSD2, GR, H6PD (PHCEC, PHKF, M1 and
M2). The primer sequences, annealing temperatures and the PCR
product sizes are detailed in Table S1. For the glucocorticoid
signaling genes, the PCR cycling conditions consisted of 94uC for
5 mins followed by 35 cycles of denaturation at 94uC for 30 sec,
annealing step for 30 sec, extension step 72uC for 30 sec and
followed by heating at 72uC for 5 mins and storage at 4uC. The
PCR products were analyzed on 2% agarose gel in 1xTBE buffer
(0.089 M Tris-base, 0.089 M boric acid, 0.002 M EDTA, pH 8.3)
and the DNA was stained with ethidium bromide and visualized
with UV light.
Cytokine analysis
PHCEC and PHKF cells at 90% confluence were treated with
TLR1-9 ligands (Invivogen) (San Diego, CA, USA) for 16 h with
cell culture medium only as negative control. The various TLR
ligands and their concentrations used were: TLR1/2 (Pam3CSK 4
1mg/ml), TLR2 (HKLM 108 cells/ml), TLR3 ((Poly(I:C) 10 mg/
ml), TLR4 (LPS 1mg/ml), TLR5 (Flagellin 1 mg/ml), TLR6 (FSL1
1 mg/ml), TLR7 (Imiquimod 1 mg/ml), TLR8 (ssRNA40 1mg/ml)
and TLR9 (ODN2006 5 mM).
Cell supernatants were collected and multiplex bead assay
analyzer (Luminex 100; Luminex Corporation, Austin, TX) was
performed with a human cytokine 30-Plex kit (Invitrogen,
Camarillo, CA) according to manufacturer’s protocol and as
previously described [26]. The panel included EGF, Eotaxin,
FGF-basic, G-CSF, GM-CSF, HGF, IFN-a, IFN-c, IL-1RA, IL-
1b, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p40/
p70, IL-13, IL-15, IL-17, CCL2, CXCL9, CCL3, CCL4, CCL5,
TNF-a, and VEGF.
Monocyte migration assays
PBMC were prepared from fresh whole blood sample from
healthy volunteers by Ficoll-Paque PLUS (GE Healthcare Life
Sciences, Amersham, UK). Briefly, whole blood was diluted by
mixing with equal volume of RPMI containing 50 000 U/L
penicillin, 50 000 mg/L streptomycin and 1% (v/v) Hepes. Diluted
blood sample was carefully layered onto the Ficoll-Paque PLUS
and centrifuged at 1200 rpm for 30 min at 20uC. PBMC was
carefully collected at the interface between the Ficoll-Paque PLUS
and sample layers. PBMC was washed with RPMI for 5 times.
Migration assays were performed with a 48-well Microchemo-
taxis Chamber (Neuro Probe, Inc., Gaithersburg,USA). The
supernatants of LPS and Poly I:C treated PHKF and PHCEC
at volume of 26 mL were loaded in the bottom wells. A slight
positive meniscus formed to prevent air bubbles from being
trapped when the filter membrane was applied. PBMC suspension
of 50 mL volume at concentration of 16106 cells/mL was loaded
in the upper wells. The Chamber was incubated at 37uC in
humidified air with 5% CO2 for 90 min. The non-migrated cells
on the top side of the filter were wiped off and washed with PBS in
a container. The filter was stained in Diff-Quick staining kit
(IMEB, San. Marcos, CA) and mounted in immersion oil on a
slide. Migrated cells were counted in three random 4006 fields by
two observers and averages of migrated cell number were
calculated.
Immunohistochemistry
Immunohistochemical analyses for the expression of TLR3,
TLR4 and CD68 were performed on formalin-fixed, paraffin-
embedded tissue sections of normal human anterior segments
enucleated for posterior segment pathologies, and from herpetic
keratitis and gram-negative keratitis tissue sections (6 mm). Antigen
retrieval was performed by heating the slides at 95uC for 1 h in
10 mM sodium citrate buffer, pH 6.0 and subsequent cooling in
cold sodium citrate buffer for 20 min. Sections were incubated
with primary antibodies at 1;100 for anti-human TLR3, TLR4
and CD68 in 1% normal donkey serum overnight at 4uC.
Following washing in PBS, biotin-conjugated secondary antibody
was diluted in 1% blocking serum and and added to sections for
45 min at room temperature at dilutions of 1:250 (donkey anti-
sheep HRP conjugate) and 1:150 (anti-rabbit). The detection was
carried using DAB substrate (Dako, Cambridge, UK) and nuclei
were counterstained using Meyer’s Haemalum (Lamb Ltd, UK).
Sections incubated in secondary antibody alone were used as
controls.
Quantification of hormones in human ocular biofluids
Tears (10 ml), aqueous humor (AqH –50 ml) and serum samples
(100 ml) were collected from 43 healthy subjects prior to cataract
surgery, and tears and serum from patients with either culture
positive gram negative bacterial (pseudomonas) keratitis (n = 6) or
PCR confirmed herpes simplex viral epithelial keratitis (n = 7)
presenting to the Accident & Emergency Department at the
Birmingham & Midland Eye Centre before initiation of treatment
or instillation of eye drops. Tears and serum were also collected
from patients with clinically quiescent chronic immune-mediated
ocular surface disease (OcSD) for a minimum of 3 months who
were not using therapeutic glucocorticoids (OcSD: Ocular Mucous
Membrane Pemphigoid (OcMMP; n= 8); SJS-TEN; n= 5).
Steroids were identified and quantified using liquid chromatogra-
phy with tandem mass spectrometry (LC/MS/MS) which
combines the physical separation capabilities of liquid chroma-
tography with the sensitivity of mass spectrometry (Waters Xevo
with Acquity uPLC), as previously described [27,28]. Each steroid
Glucocorticoids and the Ocular Surface
PLOS ONE | www.plosone.org 3 April 2014 | Volume 9 | Issue 4 | e94913
was extracted by liquid/liquid extraction and quantified by
comparison to a calibration series with respect an internal
standard, yielding quantification of unbound ‘free’ steroid
hormone. Data were converted to ng/ml and presented in nM.
All human samples were taken after written informed consent
approved by the Birmingham East, North and Solihull (BENS)
Research Ethics Committee (LREC 08/H1206/165) and from the
Black Country Research Ethics Committee (incorporating the
Dudley Research Ethics Committee (LREC 06/Q2702/63).
Statistical analysis
Statistical analysis was performed using the software package
SigmaStat (Systat Software, USA.) and Prism for Windows version
4.03c (GraphPad Software, Inc., San Diego, CA, USA). One-way
ANOVA with Dunnett’s multiple comparisons post-test (for
comparisons between untreated control and treatments) and
Two-way ANOVA with Bonferroni post-test (for comparisons
between groups of treatments) for analyses involving primary
culture data. Due to donor variability in the cytokine production,
the data have been normalized to respective untreated control
values and presented as Mean 6 SE, n= 3 donors. For biofluid
hormone levels, the data are presented as median and ranges and
analysed using two-tailed Mann-Whitney post–test for compari-
sons between group, and nonparametric Spearman-Rank corre-
lation. P values ,0.05 were accepted as statistically significant.
Results
Human corneal epithelial cells and corneal fibroblasts
produce cortisol
All cell types (PHCEC, PHKF, M1 and M2 macrophages)
showed expression of 11b-HSD1, H6PD and GRa mRNA,
whereas no cell type expressed 11b-HSD2 (Figure 1A). To
confirm whether cells were capable of generating cortisol, oxo-
reductase activity assays were performed by incubating cells with
tritiated cortisone and conversion to cortisol was measured by
using thin-layer radio-chromatography. All cell types produced
active cortisol (Figure 1B), but activity was greatest for M1
macrophages (38.1610.1 pmol/mg/h) followed by PHKF
(16.363.1 pmol/mg/h), M2 macrophages (10.263.3 pmol/mg/
h) then PHCEC (2.360.6 pmol/mg/h). There was no dehydro-
genase activity in each of the cell types. Although expression of
TLR mRNA was confirmed in these cells (Figure S1) as
previously reported, TLR 1-9 agonism did not affect 11b-HSD1
mediated cortisol production in either of the corneal cell types
(Figure 1C).
TLR induction of cytokines by human corneal epithelial
cells and fibroblasts
As previous literature had analyzed only specific cytokine
production by these cells after TLR stimulation, we wished to
address a wider cytokine profile using multiplex technology in
order to interrogate GR signaling pathways in more detail. Cells
were incubated with TLR ligands 1–9 and a ‘‘30-plex’’ multiplex
analysis for cytokine and chemokine production was performed.
Although synthesis of TNFa increased after TLR 1, 4, 7, and 9
stimulation of PHCEC this was not significant (Figure S2), and
the epithelial cells were relatively specific to TLR3 challenge only,
producing a large spectrum of cytokines and chemokines (CCL2,
IL6, CXCL-10, IL12, CCL3, CCL4, IFNc, IFNb, and CCL5)
(Figure 2A). By contrast, PHKF were weakly responsive to TLR
stimulation showing increased expression of CCL2, IL-6, CXCL8,
G-CSF CCL5 and CXCL-10. However none of these responses
reached significance. (Figure S2).
Figure 1. Pre-receptor regulation of glucocorticoids and TLR
expression in human corneal cells. (A) RT-PCR of PHCEC, PHKF
showing expression of the major genes for the pre-receptor regulation
of glucocorticoids: 11b-HSD1, 11b-HSD2, H6PD and GR. Macrophages,
M1 and M2, also express 11b-HSD1 but not 11b-HSD2. All cell types
demonstrate 11b-HSD1 oxo-reductase activity (B), most marked in M1
macrophages. (C) TLR 1–9 induction did not alter 11b-HSD1 activity in
either PHCEC or PHKF after stimulation for 16 h.
doi:10.1371/journal.pone.0094913.g001
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Glucocorticoid control of cytokine production by corneal
cells
Having identified that TLR3 and TLR4 stimulation of PHCEC
and PHKF produced maximal production of most cytokines and
chemokines we went on to assess the effects of natural and
synthetic glucocorticoids (cortisol and dexamethasone respectively)
on this process using multiplex bead analysis. The results are
expressed as fold change to compare the two treatments with
controls. Both cortisol and dexamethasone inhibited VEGF,
CCL5, IFNc, CXCL-10, CXCL8 and G-CSF production by
PHKF (Figure 3) but no change in the other cytokines measured.
There was no change any of the measured cytokines in PHCEC.
(Figure S3)
Monocyte/Macrophage infiltration in human keratitis
The interplay between infiltrating monocytes/macrophages and
corneal cells was examined. Immunohistochemistry of the normal
human central corneal tissue showed no evidence of CD68+ve
resident macrophages, and only basal TLR3 or no TLR4
expression. Stromal infiltration of CD68+ve positive cells was seen
in both herpetic and gram-negative keratitis sections (Figure 4A),
associated with TLR3 and TLR4 expression in the corneal
epithelium, respectively. The response was most pronounced in
gram-negative keratitis.
To determine if inflammatory cell infiltration into infected
corneas was mediated by PHCEC and PHKF cytokines after
TLR3 and TLR4 ligation, migration assays were performed.
Supernatants from three different donor PHCEC cultures treated
with TLR3 ligand poly I:C, induced migration of human
monocytes generated from (i) one PBMC donor ((127619%
(mean6SE) increase in migration compared with control
Figure 4B: PHCEC-S), and (ii) with one culture supernatant
from one corneal donor tested on 4 different monocyte donors
(127624% increase Figure 4C: PHCEC-D). A similar effect was
seen when PHKF were stimulated by poly I:C (Figure 4D:
PHKF-S and - Figure 4E: PHKF-D (11767% and 114611%
respectively)). Importantly, LPS (TLR4) stimulation of PHKF
produced supernatants that induced potent monocyte migration in
both experiments (Figure 4D and E 254641% for PHKF-S and
242610.8% for PHKF-D p,0.01) supporting immunohistochem-
istry data, while the effect on PHCEC was weaker (Figure 4B
and C - 87613% for PHCEC-S and 87616% for PHCEC-D
respectively). These results show a differential chemotactic
potential to TLR induction between PHCEC and PHKF.
Corneal cell supernatant control of macrophage cortisol
production
As TLR stimulation of corneal cells induced differential rates of
monocyte chemotaxis, we investigated whether the cumulative
inflammatory response was a candidate for regulating macrophage
intracrine cortisol bioavailability. There was a marked depletion of
macrophage cortisol synthesis after TLR3 challenge of both
PHCEC (230%) and PHKF (240%) (supernatants taken from the
migration experiments described above), and after TLR4
challenge (PHCEC 210%; PHKF 220%) (Figure 4F). These
data indicate that net cortisol biosynthesis is attenuated after
activation of innate signaling pathways in the ocular surface.
Relationship between glucocorticoid hormone
metabolites in human ocular biofluids, in health and
disease
Having demonstrated that corneal cells in vitro have 11b-HSD1
oxoreductase activity and that macrophage cortisol bioavailability
was inhibited following incubation with TLR stimulated corneal
cell supernatant, which could occur during chemotaxis, we sought
to investigate whether the human OcS, in vivo, was capable of
synthesizing cortisol from cortisone in healthy eyes and during
Figure 2. Human corneal cells respond to TLR stimulation by
producing cytokines. Multiplex bead ELISA analysis (Plex-30) of
cytokine production in response to TLR 1–9 stimulation for 16 hours is
shown. Cytokines analysed included: IL-1b, IL-1Ra, IL-2, IL-4, IL-5, IL-6, IL-
7, IL-8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, Eotaxin, Basic FGF, G-CSF,
GM-CSF, IFN-c, CXCL-10, CCL2, CCL3, CCL4, PDGF-BB, CCL5, TNF-a,
VEGF. Induction of a range of cytokines and chemokines was seen after
TLR 3 challenge (CCL2, CCL3, CCL4, CCL5, CXCL10, IL1, IFNc and IFNb).
Values = Mean+SE, n = 3, Statistical analysis was carried using One-way
ANOVA and comparisons were drawn with untreated control Vs TLR
stimulated cells. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0094913.g002
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active infective keratitis or putative TLR 3 mediated OcSD
disease. We used a highly sensitive technique of LC/MS/MS and
quantified GC metabolites in human ocular biofluid compart-
ments as surrogates for OcS (tears) and intraocular (AqH)
steroidogenesis, versus peripheral blood (serum).
(i) Normal healthy eyes. Both cortisone and cortisol were
detected in all three bio-fluid compartments in the proportion
serum= tears.AqH and serum.tears =AqH, respectively
(Figure 5 A–B). No gender difference was observed. Both ocular
biofluids showed positive correlation between cortisone and
cortisol levels, AqH (r = 0.98, p,0.0001, Figure 5C) and tears
(r = 0.79, p,0.001, Figure 5D), but there was no correlation
between serum cortisol and cortisone versus that found in tears or
AqH (Figure 5E–H) indicating that simple diffusion from the
peripheral circulation into the tear film and AqH was not likely to
be the main source of these hormones. Cortisone and cortisol
levels were consistently higher in tears versus AqH where a
positive correlation was observed between tear cortisol vs AqH
cortisol (r = 0.79, p,0.003) (Figure 5I–J), suggesting that the tear
film may be the driver for AqH cortisol, delivering either active
cortisol into the anterior chamber or substrate (cortisone) for
intraocular 11b-HSD1. The cortisol:cortisone ratio (a marker of
11b-HSD1 oxo-reductase activity) showed cortisol:cortisone ratios
in AqH (3:1) exceeded those in tears (1:1) in healthy individuals
(Figure 5K). These data suggest greater 11b-HSD1 activity
within the eye than on the surface of the eye in normal
physiological states. There was no relationship between age or
gender on cortisol or cortisone levels, or cortisol:cortisone ratios, in
each of the ocular bio-fluids (Figure S4A (cortisol), S4B
(cortisone), S4C (cortisol:cortisone)).
(ii) Infective keratitis and immune-mediated ocular
surface disease. Having established that the healthy human
OcS is capable of generating cortisol from cortisone in vivo, and
that in vitro induction of TLR3 and TLR4 in PHCEC and PHKF
triggered pro-inflammatory cytokine production with subsequent
macrophage migration and abrogation of immune-cells cortisol
biosynthesis, we sought to establish whether the tear film
glucocorticoid profile was altered in patients with untreated
herpetic and pseudomonas keratitis presenting to the emergency
room, and those patients with chronic immune-mediated ocular
surface inflammatory disease. These data showed that the mean
(6SEM) free cortisol in healthy volunteer tear film 85.6(0–1306.2)
nM/L was lower than in patients with acute herpes simplex
keratitis (288.1(136.5–434.1) nM/L) and pseudomonas keratitis
(223.0 (154.9–418.6) nM/L). These data equated to cortisol:corti-
sone ratios of 1.33(0.39–131.3) in the healthy tear film versus
0.33(0.0–0.50) (p,0.01) in patients with pseudomonas keratitis
and 1.42(0.12–6.44) (p = 0.42) in herpes simplex keratitis
(Figure 6), confirming an attenuation of OcS cortisol biosynthesis
(and 11b-HSD1 activity) in vivo during active OcS pseudomonas
Figure 3. Regulation of cytokine production with Cortisol/Dexamethasone on TLR3 or TLR4 stimulated Primary Human Corneal
Fibroblasts (PHKF). Both cortisol (&, black square) and dexamethasone (&, gray square) reduced cytokines: VEGF, CCL5, IFN-c, CXCL-10, IL-8 and
GCSF (B) after either or both TLR 3 and 4 stimulation of PHKF. (Values = Mean+SE, normalising to No Cortisol/Dexamethasone (%, white square) for
each treatment n = 3; Statistical analysis 2-way ANOVA with Bonferroni post-test; *p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0094913.g003
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infection (supporting in vitro data (Figure 4E)). By contrast,
cortisol:cortisone ratios were increased in patients with chronic
(putative TLR 3 regulated) immune-mediated OcS disease states
(OcMMP, 9.05(0.9–20.7); SJS/TEN, 113.8(11.73–1070.0
(p,0.01) (Figure 6).
Discussion
In the human eye, the ocular surface provides the first line of
defense to potential exogenous triggers, but is also a target for
autoimmune disease. The surface is a non-keratinized mucosa
with a unique avascular component known as the cornea, critical
for refracting light and for sight. The cornea is considered to be an
immune privileged site exhibiting both immunological ignorance,
but also a range of active immunosuppression mechanisms [29]
that infer a 90% 5 year survival rate of low risk corneal allografts
[30,31]. Several pathways have been purported to be involved in
the immune-privileged status of the eye including a range of
systemic and neural factors, in addition to local intraocular
mechanisms such as soluble immunosuppressive agents in the
aqueous humour [a-melanocyte stimulating hormone (aMSH),
vasoactive intestinal peptide (VIP), transforming growth factor-b2
(TGF-b2), IL-1Ra, somatostatin, cortisol][32–34] or cell surface
molecules (CD95-L, B7H1, MHC Class Ib, CD46, CD55, CD59)
[35].
Adrenal hormones are known to be regulators of ocular surface
health and dry eye induced inflammation [36–40]. Our previous
work has indicated that endogenous production of GCs mediated
by the isozyme 11b-HSD1 may also be a contributing factor,
specifically ocular surface renewal and putative barrier function
[3,15]. 11b-HSD1 is involved in several disease processes
including insulin resistance, osteoporosis, obesity, idiopathic
intracranial hypertension, glaucoma, orbital adipogenesis, inflam-
mation and immune cell function [3,28,32,41–43].
While a small resident population of myeloid cells populate the
central cornea [44], critical to clearing infection is the recruitment
of phagocytes (macrophages and iDCs) to the site of infection and
these cells too, appear to be mediated in part, by local cortisol.
There is an enhanced ability of myeloid-derived immune cells to
produce cortisol after TLR-induced maturation signals. This is
associated with an increased expression of MHC class I and class
II, CD40L and synthesis of pro-inflammatory cytokines, leading to
inflammation at the site of infection [20]. Conversely, maturation
of iDCs induced by CD40 ligation not only leads to a fall in the
ability of DCs to produce cortisol, differentiation of DCs from
Figure 4. Macrophage infiltration in human keratitis. (A) Immunohistochemistry of the normal human central corneal epithelium showed no
evidence of CD68 positive resident macrophages or basal TLR4 expression, although there was some basal TLR3 expression. Corneal stromal
infiltration of CD68 positive cells is seen in both herpetic and gram negative keratitis associated with increased TLR3 and TLR4 expression in the
corneal epithelium, respectively. (B–E) Migration assay showing culture supernatants of corneal cells having chemotactic potential on monocytes. Cell
supernatants from PHCEC/PHKF stimulated with TLR3 (poly I:C) or TLR4 (LPS) ligands for 16 h were tested for the ability to induce monocyte
migration. ‘S’ denotes culture supernatants from PHCEC/PHKF cultures generated from 3 corneal donors, tested on a single allogenic PBMC donor. ‘D’
denotes 3 different PBMC donors subjected to culture supernatant from a single donor derived PHCEC/PHKF treated with TLR3 and TLR4 ligands.
Data show that both LPS and Poly I:C stimulation of corneal cells induce monocyte migration but LPS stimulation of PHKF has the greatest
chemotactic potential. (Panels D and E). (F) Culture supernatants from experiments A–D (TLR3 and TLR4 induction of PHCEC/PHKF for 16 h)
downregulates M1 macrophage 11b-HSD1 activity. Statistical analysis was carried using one-way ANOVA and comparisons were drawn with
untreated control cells vs. TLR3/TLR4 treated cells.
doi:10.1371/journal.pone.0094913.g004
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monocyte precursors is inhibited by physiological concentrations
of cortisone, indicating that inactive GC acts as an autocrine-
negative regulator of DC maturation thereby imposing a
checkpoint on differentiation of monocytes to mature DCs [24,25].
In this study, we examined the tissue-specific cortisol regulation
by human corneal cells in the context of immune responses to
TLR ligation, and how this could have impact on clinical disease.
Both PHCEC and PHKF cells were shown to express major
components of the glucocorticoid pre-receptor signaling pathways
consistent with earlier human and rabbit studies [3,14]. These cells
were capable of producing cortisol, although the rate of conversion
was less than that of M1 and M2 macrophages. In our study, TLR
ligation in vitro did not alter cortisol bioavailability but elicited cell-
specific cytokine and chemokine release, including TNFa only
Figure 5. Hormones detected in human ocular biofluids versus serum. A) Cortisone and (B) cortisol levels in the tear film and AqH. There
was no gender dependency for any of the analyte (N black circle, Male and (& red square, Female)). There was a positive correlation between cortisol
and cortisone in both ocular biofluids (C–D), but concentrations were largely independent of those found in serum (E–H). There was an association
between AqH and Tear film cortisone (I) and cortisol (J), and cortisol:cortisone (F:E) ratios were consistently higher in AqH versus the tear film (K).
doi:10.1371/journal.pone.0094913.g005
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after TLR 1, 4, 7, and 9 stimulation of PHCEC; and CCL2, IL-6,
CXCL8, G-CSF after TLR 1–8 stimulation of PHKF. Cytokine
induction however, was regulated by the presence of synthetic
(dexamethasone) and natural (cortisol) GCs in PHKF only, but
only TNFa in PHCEC. This dichotomy is of interest, and the
relative resistance of PHCEC to glucocorticoids is the focus of
future study.
Stimulation of PHCEC with TLR ligands showed that only poly
I:C could induce multi-cytokine synthesis. The range of molecules
produced, include proinflammatory cytokines IL-12 and IFNc
indicative of a Th1 mediated adaptive response, chemokines
CCL3, CCL4, and CCL5 that are associated with mononuclear
cell recruitment, and IFNb that has both antiviral and immuno-
suppressive function. There is a particularly strong increase in
CXCL10 production after ligation of TLR 3 in both cell types and
also TLR4 in HKF. This is of interest as this cytokine has
pleiotropic function including angiostasis due to its lacking an ELR
motif (Glu-Leu-Arg tripeptide sequence). In CXCL10 deficient
mice, an increase in liver fibrosis is seen due to inhibition of
natural killer cells (NK) which target hepatic stellar cells [45]. In
murine corneal infection with Herpes simplex virus, depletion of
NK cells leads to loss of viral control [46]. As TLR3 recognizes
double-stranded RNA these data support an inductive role for
PHCEC in response to infection or possibly TLR3 related
immune-mediated disease e.g. SJS-TEN, dry eye disease states,
may induce an increase in CXCL10 and a reduction in NK cells
exacerbating infection or persistence of inflammation. With the
exception of TNFa, the failure of other TLR ligands to induce
cytokines by PHCEC has been suggested to be due to the
intracellular expression of TLR2 and TLR4 in PHCEC, receptors
that are normally expressed on the cell surface [47]. It is also
possible that PHCEC do not have the co-receptors necessary for
TLR signaling, although CD14 expression has been reported [48].
This relative inertness of the corneal epithelium may be a
contributory factor to barrier function, and it is possible that
breaches of this barrier are required to trigger resident stromal
keratocytes to differentiate into an activated fibroblast phenotype
with subsequent wider cytokine response, as shown in our study.
Activated fibroblasts may therefore represent sentinels for ocular
surface inflammation. Regardless, the stimulation of TLR3
strongly suggests and supports the concept that the human OcS
produces a vigorous immune response possibly underpinning
reactivation of viral keratitis and exacerbations of inflammation in
chronic OcS immune-mediated disease [18,21–23].
Responses in PHKF to TLR ligands were inhibited by the
addition of exogenous glucocorticoids. Unlike monocyte–derived
cells [24,49]. TLR stimulation had no effect on cortisol
biosynthesis by PHCEC or PHKF. By comparison, blood-derived
macrophages, particularly M1 cells showed 3-fold greater
production of cortisol compared to ocular cells. These data
suggest that infiltrating inflammatory (M1) macrophages are
capable of controlling not only their own inflammatory processes,
but also ocular surface cytokine production via paracrine cortisol
control. While endogenous cortisol has been shown in several
studies to down-regulate MHC class II, co-stimulatory molecules
(CD80, CD86) and the ability to activate allogeneic cells,
inhibition of endogenous cortisol can also lead to a reduction in
IL-1 and TNFa. A recent study has shown that IL-17 may
orchestrate resolution of innate inflammation, whereas IFN-c and
IL-4 may represent major determinants of IL-10 and glucocorti-
coid resistance [50].
The potential role of cortisol produced by corneal cells versus
that produced by infiltrating macrophages is of considerable
interest [51–54]. The differing response to TLR induction
between ocular surface epithelial cells and macrophages may be
an element of silencing induced by coexistent protective
commensal bacteria, a mechanism seen in the gut vital intestinal
homeostasis [55]. Breaches in intestinal epithelial cell cross-
communication with gut flora provide the basis of inflammatory
bowel disease and this may be relevant in driving ocular surface
disease pathogenesis.
Using the novel technique of LC/MS/MS we have been able to
detect cortisol and cortisone levels in human ocular bio-fluids as
functional readouts of tissue specific regulation of cortisol. Overall,
cortisol levels were greater than those reported in other bio-fluids
such as CSF [28], saliva [56] and skin microdialysis [57]. Cortisol
concentrations at the ocular surface consistently exceeded those in
the intraocular aqueous humor amongst healthy human subjects
in a consistent pattern of expression (serum.tears.AqH) with no
gender variations observed. Correlations of cortisol in ocular bio-
fluids versus those found in serum, confirmed that ocular cortisol
was potentially independent of circulatory cortisol. By contrast,
intraocular cortisol and cortisone correlated with that on the
ocular surface (consistently tears.AqH). Cortisol:cortisone (F:E)
ratios (an in vivo biomarker of 11b-HSD1 enzyme activity) were
greater within aqueous humor than in the tear film. These data
indicate that the OcS cortisol-cortisone shuttle may be the driver
for intraocular cortisol, either by delivering cortisol directly into
the anterior chamber of the eye or substrate for 11b-HSD1. In
patients with acute presentation of pseudomonas keratitis, the net
ocular surface cortisol:cortisone ratios were significantly reduced,
suggesting either an abrogation of cortisol is required to allow
inflammatory cell migration to eradicate infection, or an increased
utilization of cortisol in an acute bacterial disease state. These data
supported our in vitro findings that demonstrated a reduction in
macrophage 11b-HSD1 oxo-reductase activity when challenged
by a cytokine cocktail produced by either PHCEC or PHKF
induced by TLR4 ligation. It would be interesting to interrogate
longitudinal tear film glucocorticoid profiles during clinical disease
Figure 6. Ocular surface glucocorticoid bioavailability in health
and disease. Evaluation of tear film glucocorticoid profiles as
surrogate readouts of net ocular surface glucocorticoid bioavailability,
defines cortisol depletion (reduced cortisol:cortisone (F:E ratio,
mean6SE) during active untreated pseudomonas keratitis (PSK) but
not herpes simplex keratitis (HSK), and amplification during chronic
clinically quiescent immune-mediated disease (MMP, mucous mem-
brane pemphigoid; SJS/TEN, Stevens-Johnson Syndrome/Toxic-epider-
mal Necrolysis). Statistical analysis performed using t-test with two-
tailed Mann Whitney post -test. * = P,0.05.
doi:10.1371/journal.pone.0094913.g006
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course, to determine whether specific profile patterns correlate
with the sterilization and healing phases of infective corneal
disease. Although there appeared to be no change in net tear film
cortisol:cortisone ratios in patients with untreated herpes simplex
keratitis, there was a marked intensification of cortisol compared
to cortisone in patients with chronic immune-mediated disease
states not using local or systemic therapeutic glucocorticoids.
TLR3 is an integral player in chronic SJS-TEN [23], experimental
inflammatory dry eye [19] and hypersensitivity responses in the
conjunctiva [58]. While the local regulation of cortisol is clearly
important in physiological and innate immune responses in the
eye, the role is multifaceted and the mechanisms underpinning
therapeutic glucocorticoid use is highly complex. The data though
intriguing is based on small numbers of patients with each disease
and further investigation is necessary to explore these data further,
with the potential for longitudinal studies an important consider-
ation
In summary, we have shown that intracrine cortisol biosynthesis
in human corneal cells is independent of TLR activation and is
likely to afford immuno-protection under physiological conditions
(Figure 7A). During microbial or immune-mediated challenge,
release of cytokines from these cells, trigger migration of
monocytes and differentiation to macrophages that in turn are
capable of generating large quantities of cortisol that contribute to
resolution of the local inflammatory response thereby maintaining
optical clarity (Figures 7B and C). Nevertheless, in vivo, the net
OcS cortisol measured in the tear film is dependent on the nature
of the OcS disease and a reduction in acute infection or an
increase during chronic immune-mediated disease, is observed.
These data indicate that OcS generation of cortisol contributes to
ocular mucosal innate responses, but its role is complex and
dependent on the cell type and nature of the underlying
immunological challenge.
Supporting Information
Figure S1 Expression of TLRs in Primary Corneal
Cells. PHCEC expressed TLR1, TLR2, TLR3, TLR4 and
TLR10 mRNA, while PHKF expressed mRNA for TLR 1–4, and
TLR9-10. GAPDH was used as a housekeeping gene and distilled
water (DW) alone as the negative control.
(TIF)
Figure S2 Cytokine Expression after TLR Stimulation
of Primary Corneal Cells. Multiplex bead ELISA analysis
(Plex-30) of cytokine production in PHCEC and PHKF in
response to TLR 1–9 stimulation for 16 hours is shown. Cytokines
analysed included: IL-1b, IL-1Ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-
8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, Eotaxin, Basic
FGF, G-CSF, GM-CSF, IFN-c, CXCL-10, CCL2, CCL3, CCL4,
PDGF-BB, CCL5, TNF-a, VEGF. TNFa increased after TLR 1,
4, 7, and 9 stimulation of PHCEC and IL6 after TLR 3. (B) PHKF
were variably responsive to TLRs 1–8 producing non-significant
induction of G-CSF, CCL2, IL-6, IL-8, CXCL10 and CCL5.
Values = Mean+SE, n= 3, Statistical analysis was carried using
One-way ANOVA and comparisons were drawn with untreated
control Vs TLR stimulated cells.
(TIF)
Figure S3 Effect of Glucocorticoids on the Production of
Corneal Cell Cytokine Production. Both Dexamethasone
(&, grey square) and cortisol (&, black square) had no effect on
the production of the cytokines (VEGF, CCL2, IL-6, IL-12,
GCSF, IFN-Y,CXCL10, IL-8) after TLR 3 and 4 stimulation in
PHCEC. However, for PHKF, the cytokines MCP-1 and Il-6 were
over the detection limit and TNF-a and IL-12 were below the
detection limit and the effect of cortisol or dexamethasone could
not be verified on these cytokines. (Values = Mean+SE, n= 3
normalized to no Cortisol/Dexamethasone %, white).
(TIF)
Figure S4 Correlation studies of glucocorticoid bio-
availability in the human eye with age. There was no
correlation between cortisol and cortisone and their ratios in both
ocular biofluids (Tears or AqH) with age or gender (A–C).
(TIF)
Table S1 Oligonucleotide sequences of PCR primers.
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